
Improving Access to PrEP in Rhode Island
Status:
Rhode Island’s H6150 will expand access to pre-exposure prophylaxis (PrEP) – a game-changing medication that reduces the risk of HIV transmission by close to 100 percent.
H6150 lets pharmacists provide a patient with a short-term supply (60 days once in a two-year period) of PrEP without a prescription. Pharmacists will be required to provide counseling on the use of PrEP and connect patients without a primary care provider with health care providers for ongoing medication and care.
H6150 also requires insurers to cover one type of PrEP within each method of administration without cost-sharing or prior authorization. These provisions are critical but should go further to remove obstacles to PrEP.
Related Content
-
GLAD Testifies in Opposition to Proposed HIV Criminalization Legislation in Rhode Island
Read MoreGLAD AIDS Law Project Director and Senior Staff Attorney Ben Klein testified before the Rhode Island House Judiciary Committee February…